Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009).
Citation
Omosa-Manyonyi G, Jaoko W, Anzala O, Ogutu H, Ndambuki R, Wakasiaka S, Malogo R, Kayitenkore K, Karita E, Schmidt C, Fast P, Komaroff W, Cooper A, Boaz M, Gilmour J, Dally L, Ho M, Smith C, Graham B. Safety and immunogenicity of the VRC recombinant multiclade HIV-1 adenoviral vector vaccine alone or in combination with the VRC multiclade HIV-1 DNA plasmid vaccine in healthy African adults (2009). Oral presentation at The Kenya Medical Association 36th Annual Scientific Conference (2008)Publisher
University of Nairobi School of Medicine